...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors.
【24h】

Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors.

机译:小鼠的急性和慢性海洛因依赖性:阿片样物质和兴奋性氨基酸受体的贡献。

获取原文
获取原文并翻译 | 示例
           

摘要

Opioid and excitatory amino acid receptors contribute to morphine dependence, but there are no studies of their role in heroin dependence. Thus, mice injected with acute or chronic heroin doses in the present study were pretreated with one of the following selective antagonists: 7-benzylidenenaltrexone (BNTX), naltriben (NTB), nor-binaltorphimine (nor-BNI; delta1, delta2, and kappa opioid receptors, respectively), MK-801, or LY293558 (NMDA and AMPA excitatory amino acid receptors, respectively). Naloxone-precipitated withdrawal jumping frequency, shown here to be a reliable index of heroin dependence magnitude, was reduced by BNTX or NTB in mice injected with both acute and chronic heroin doses. In contrast, nor-BNI did not alter jumping frequencies in mice injected with an acute heroin dose but significantly increased them in mice receiving chronic heroin injections. Continuous MK-801 or LY293558 infusion, but not injection, reduced jumping frequencies during withdrawal from acute heroin treatment. Their delivery by injection was nonetheless effective against chronic heroin dependence, suggesting mechanisms not simply attributable to NMDA or AMPA blockade. These data indicate that whereas delta1, delta2, NMDA, and AMPA receptors enable acute and chronic heroin dependence, kappa receptor activity limits the dependence liability of chronic heroin. With the exception of delta1 receptors, the apparent role of these receptors to heroin dependence is consistent with their contribution to morphine dependence, indicating that there is substantial physiological commonality underlying dependence to both heroin and morphine. The ability of kappa receptor blockade to differentially alter acute and chronic dependence supports previous assertions from studies with other opioids that acute and chronic opioid dependence are, at least in part, mechanistically distinct. Elucidating the substrates contributing to heroin dependence, and identifying their similarities and differences with those of other opioids such as morphine, may yield effective treatment strategies to the problem of heroin dependency.
机译:阿片样物质和兴奋性氨基酸受体促成吗啡依赖性,但尚未研究它们在海洛因依赖性中的作用。因此,在本研究中,注射了急性或慢性海洛因剂量的小鼠用以下一种选择性拮抗剂进行了预处理:7-亚苄基神经trexone(BNTX),naltriben(NTB),nor-binaltorphimine(nor-BNI; delta1,delta2和κ阿片受体),MK-801或LY293558(分别为NMDA和AMPA兴奋性氨基酸受体)。纳洛酮沉淀的戒断跳跃频率(此处显示为海洛因依赖程度的可靠指标)在注射急性和慢性海洛因剂量的小鼠中被BNTX或NTB降低。相反,nor-BNI不会改变注射海洛因急性剂量的小鼠的跳跃频率,但会明显增加接受慢性海洛因注射的小鼠的跳跃频率。连续MK-801或LY293558输注(但不注射)可降低急性海洛因治疗退出期间的跳跃频率。尽管如此,通过注射递送它们仍有效对抗慢性海洛因依赖性,提示机制不仅仅归因于NMDA或AMPA阻滞。这些数据表明,虽然delta1,delta2,NMDA和AMPA受体能够引起急性和慢性海洛因依赖性,但kappa受体的活性限制了慢性海洛因的依赖性。除delta1受体外,这些受体对海洛因依赖性的明显作用与其对吗啡依赖性的贡献是一致的,表明对海洛因和吗啡的依赖性具有实质性的生理共性。 κ受体阻滞剂差异改变急性和慢性依赖性的能力支持了先前与其他阿片类药物研究的断言,即急性和慢性阿片类药物依赖性至少部分在机制上是不同的。阐明造成海洛因依赖性的底物,并确定它们与其他阿片类药物(如吗啡)的异同,可能会产生有效的治疗策略来解决海洛因依赖性问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号